Announcements
- Orphan Drug Designation & FDA INTERACT Meeting
- Grant of Options – PDMR/Director Dealings
- Holding(s) in Company
- BiVictriX Hosts Inaugural Roundtable Discussion
- Board Change
- Pipeline update on BVX002
- Patent Granted in Japan
- Extended Survival Rates Reported with BVX001
- Appointment of Adrian Howd as CFO and CBO
- Interim Results
More ▼
Key statistics
As of last trade, BiVictriX Therapeutics PLC (4DE:FRA) traded at 0.126, 23.53% above the 52 week low of 0.102 set on Jan 03, 2024.
52-week range
Open | 0.128 |
---|---|
High | 0.128 |
Low | 0.126 |
Bid | 0.126 |
Offer | 0.145 |
Previous close | 0.126 |
Average volume | 0.00 |
---|---|
Shares outstanding | 82.53m |
Free float | 52.28m |
P/E (TTM) | -- |
Market cap | 9.49m GBP |
EPS (TTM) | -0.0352 GBP |
Data delayed at least 15 minutes, as of May 07 2024 08:59 BST.
More ▼